Pierre Gravier is a director of Cassava Sciences Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 24 | PTCT PTC Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,100 | 0.00 | 55,800 |
15 Feb 24 | PTCT PTC Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 19,000 | 0.00 | 52,700 |
15 Feb 24 | PTCT PTC Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.69 | 47,500 | 1.22 mm | 47,500 |
12 Dec 23 | PTCT PTC Therapeutics | Common Stock | Buy | Acquire P | No | No | 25.8099 | 7,700 | 198.74 k | 33,700 |
6 Dec 23 | SAVA Cassava Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 21.71 | 20,000 | 434.20 k | 20,000 |